DSM and Phynova reach global distribution agreement for blood glucose-support ingredient

March 22, 2019

Phynova has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM.

Phynova (Oxfordshire, UK) has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM (Kaiseraugst, Switzerland). Reducose is a patented water extract of white mulberry leaves (Morus alba) that supports healthy blood glucose levels by reducing the absorption of sugars and other carbohydrate by up to 40%, says the company.

“We are delighted to work with DSM, the leading global health and nutrition ingredient specialist,” said Robert Miller, CEO of Phynova, in a press release. “Along with the distribution and sales of Reducose, we will collaborate closely with them on product development, clinical research, regulatory approvals, and marketing.”

“Phynova is a strategic partner for DSM to provide the right nutritional solutions to address the ever-growing health concerns linked to maintaining healthy blood glucose,” explained Ivo Lansbergen, VP global strategic marketing, DSM Human Nutrition and Health, in a press release. “The combined strengths of DSM and Phynova provide an excellent platform for addressing this major societal challenge.”